Sign up for updates
Be the first to know when new information and articles become available.
Register nowFind answers to common questions about living with cancer during the COVID-19 pandemic
From the National Cancer Institute (NCI)
The questions and answers below were originally published by the National Cancer Institute (NCI), the US government’s main agency for cancer research.
Information about the COVID-19 pandemic is always changing. Ask your doctor any questions you have about COVID-19 and how it may affect you and your treatment.
Coronaviruses are a large family of viruses that are common in people and many different species of animals. SARS-CoV-2 is a novel (new) coronavirus that causes a respiratory disease named coronavirus disease 2019, which is abbreviated to COVID-19.
If you have cancer, you have a higher risk of severe COVID-19. Other factors that increase the risk for severe COVID-19 include having a weakened immune system (being immunocompromised), older age, and other medical conditions.
People with blood cancers may be at higher risk of prolonged infection and death from COVID-19 than people with solid tumors. That is because patients with blood cancers often have abnormal or depleted levels of immune cells that produce antibodies against viruses.
If you had cancer in the past, you also may be at higher risk of severe COVID-19, and you may want to discuss your concerns about COVID-19 with your doctors.
Yes. The Centers for Disease Control and Prevention (CDC) recommends that everyone age 6 months and older stay up to date with COVID-19 vaccination, including all primary series doses and boosters. That includes most people with underlying medical conditions, including cancer.
If, like most people (including most people who had cancer in the past), you have a healthy immune system, CDC recommends that you follow this vaccine schedule for people who are not moderately or severely immunocompromised.
People with certain cancers and those who are receiving treatment that suppresses the immune system may have a weaker response to COVID-19 vaccines than people whose immune systems are not compromised.
You may be moderately or severely immunocompromised if you:
If you recently received cancer treatment that suppresses the immune system—such as chemotherapy, a stem cell or bone marrow transplant, or cell therapy—your doctor may suggest that you wait until your immune system has recovered before you get vaccinated. Or your doctor may suggest that you wait a few weeks after vaccination to get immunosuppressive treatment.
Talk with your doctors if you think you may need to be revaccinated.
Aside from vaccination, the most effective way to prevent COVID-19 is to avoid being exposed to the virus that causes it. To protect yourself and prevent the spread of COVID-19, take precautions:
Your family members, loved ones, and caregivers can help protect you and other people at high risk of serious COVID-19 by following these precautions, too.
If you think you have been exposed to COVID-19 or have symptoms of an infection, you should get a COVID-19 test. If the test shows that you have COVID-19, isolate yourself from others and call your health care provider.
Treatments are available for people who test positive and are more likely to get very sick from COVID-19. These treatments must be given within a few days after symptoms begin, even if your symptoms are still mild.
If you are being treated for cancer and need treatment for COVID-19, your health care providers should consider potential drug interactions with your cancer therapies or overlapping side effects. In some cases, your cancer treatment may need to be paused or modified while you receive treatment for COVID-19.
Coping with cancer in the face of the coronavirus can bring up a wide range of feelings you’re not
used to dealing with. Your doctor may have some resources that can help you cope through your
cancer journey.
NCI’s Cancer Information Service (CIS) can help answer questions about COVID-19 or your cancer care, and can be reached by telephone or live chat.
Be the first to know when new information and articles become available.
Register now